Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 364 (9440), 1141-1148
- https://doi.org/10.1016/s0140-6736(04)17100-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trialsThe Lancet Infectious Diseases, 2003
- A note on statistical methods for assessing therapeutic equivalenceControlled Clinical Trials, 2002
- Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trialThe Lancet, 2002
- Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in PakistanArchives of Disease in Childhood, 2002
- Estimates of world-wide distribution of child deaths from acute respiratory infectionsThe Lancet Infectious Diseases, 2002
- Magnitude of the problem of childhood pneumoniaThe Lancet, 1999
- Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trialThe Lancet, 1998
- Clinical signs that predict death in children with severe pneumoniaThe Pediatric Infectious Disease Journal, 1989
- Determinants of Morbidity and Mortality Due to Acute Respiratory Infections: Implications for InterventionThe Journal of Infectious Diseases, 1988
- Etiology of severe pneumonia in children in developing countriesThe Pediatric Infectious Disease Journal, 1986